Novo Nordisk正在全球解雇9,000名工人, 包括在美国, 以降低成本, Novo Nordisk is laying off 9,000 workers globally, including in the U.S., to cut costs amid slowing sales and rising competition.

Novo Nordisk已开始在美国裁员, 这是由新任CEOMike Doustdar领导的全球结构调整的一部分, 针对多个部门, 包括销售、营销和临床开发。 Novo Nordisk has begun layoffs in the U.S., part of a global restructuring under new CEO Mike Doustdar, targeting multiple departments including sales, marketing, and clinical development. 该公司计划在丹麦裁员5 000人之后,削减全世界9 000个就业机会,因为该公司在Wegovy销售减慢和Eli Lilly的竞争日益激烈的情况下,力求降低成本。 The company plans to cut 9,000 jobs worldwide, following 5,000 layoffs in Denmark, as it seeks to reduce costs amid slowing sales of Wegovy and growing competition from Eli Lilly. 预计受影响的美国雇员将在今后几天得到通知。 Affected U.S. employees are expected to be notified in the coming days. 此举的目的是提高效率,注重肥胖症和糖尿病治疗,自该计划宣布以来,这一比例上升了约6%。 The move aims to improve efficiency and focus on obesity and diabetes treatments, with shares rising about 6% since the plan was announced.